A Novel Method of Mobilizing Leukemia Initiating Cells by a Small Molecule Cdc42 Activity-Specific Inhibitor (CASIN) for Acute Myeloid Leukemia Therapy

被引：0
|
作者：
Liu, Wei [1 ]
Mizukawa, Benjamin [2 ]
Wunderlich, Mark
Johnson, James F.
Mulloy, James C.
Zheng, Yi
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Mol & Dev Biol Program, Div Expt Hematol & Canc Biol, Cincinnati, OH USA
[2] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 40 条
  • [1] Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
    Duan, Xin
    Perveen, Rehana
    Dandamudi, Akhila
    Adili, Reheman
    Johnson, James
    Funk, Kevin
    Berryman, Mark
    Davis, Ashley Kuenzi
    Holinstat, Michael
    Zheng, Yi
    Akbar, Huzoor
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
    Xin Duan
    Rehana Perveen
    Akhila Dandamudi
    Reheman Adili
    James Johnson
    Kevin Funk
    Mark Berryman
    Ashley Kuenzi Davis
    Michael Holinstat
    Yi Zheng
    Huzoor Akbar
    [J]. Scientific Reports, 11
  • [3] Mobilization of Hematopoitic Stem/Progenitor Cells by a Cdc42 Activity-Specific Inhibitor
    Liu, Wei
    Wang, Lei
    Shang, Xun
    Guo, Fukun
    Ryan, Marnie A.
    Geiger, Hartmut
    Zheng, Yi
    [J]. BLOOD, 2008, 112 (11) : 32 - 33
  • [4] Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
    Fukushima, Nobuaki
    Minami, Yosuke
    Kakiuchi, Seiji
    Kuwatsuka, Yachiyo
    Hayakawa, Fumihiko
    Jamieson, Catoriona
    Kiyoi, Hitoshi
    Naoe, Tomoki
    [J]. CANCER SCIENCE, 2016, 107 (10) : 1422 - 1429
  • [5] Small Molecule Inhibition of SIRT Activity: A Novel Therapeutic Approach for Acute Myeloid Leukemia
    Nawrocki, Steffan T.
    Espitia, Claudia M.
    Kelly, Kevin R.
    Bornmann, William G.
    Carew, Jennifer S.
    [J]. BLOOD, 2011, 118 (21) : 40 - 40
  • [6] Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia
    Lap, Coen J.
    Abrahim, Marwa S. H.
    Nassereddine, Samah
    [J]. ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2215 - 2229
  • [7] SMALL-MOLECULE INHIBITOR TARGETING P62 ATTENUATES THE LEUKEMIA-INITIATION POTENTIAL OF ACUTE MYELOID LEUKEMIA CELLS
    Li, Yafang
    Yin, Jingjing
    Gu, Jiali
    Li, Yinghui
    Xie, Xiangqun
    Gao, Yingdai
    [J]. EXPERIMENTAL HEMATOLOGY, 2019, 76 : S74 - S74
  • [8] Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy
    Nishida, Yuki
    Maeda, Aya
    Chachad, Dhruv
    Ishizawa, Jo
    Qiu, Yi Hua
    Kornblau, Steven M.
    Kimura, Shinya
    Andreeff, Michael
    Kojima, Kensuke
    [J]. CANCER SCIENCE, 2015, 106 (12) : 1705 - 1713
  • [9] The effect of small molecule inhibitor NSC348884 on nucleophosmin 1-mutated acute myeloid leukemia cells
    Zhu, J. -F.
    Han, L. -L.
    Ma, Y.
    Wang, Y. -X.
    Zhang, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (19) : 9145 - 9151
  • [10] Targeting Pim Kinase Activity with the Novel Small Molecule Inhibitor SGI-1776 Significantly Augments the Efficacy of Cytarabine In Models of Acute Myeloid Leukemia
    Kelly, Kevin R.
    Oberheu, Kelli
    Medina, Ernest
    Espitia, Claudia M.
    Mahalingam, Devalingam
    Taverna, Pietro
    Choy, Gavin S.
    Nawrocki, Steffan T.
    Giles, Francis J.
    Carew, Jennifer S.
    [J]. BLOOD, 2010, 116 (21) : 1334 - 1334
1234